Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 13 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Apparatus and method for information processing, program, and recording medium
String changing tool with a quick connector assembly and worm gear string cutter
Apparatus, system, and method for non-interruptively updating firmware on a redundant hardware controller
Selective facsimile denial
Personal alarm device for headwear for proximity detection
Prioritizing application data for transmission in a wireless user device
Fiber optic cables and assemblies for fiber toward the subscriber applications
  Randomly Featured Patents
Method and apparatus for using an on-board temperature sensor on an integrated circuit
Flashing brake light system
Vibratory and gas levitation particle treatment system
Hair care appliance package
Backlight assembly and display device having the same
Process for the production of polysulfide silane compounds
Dispenser for flexible cutting line
Adjustable latching mechanism
Process to obtain new mixed copper aminoactidate complexes from phenylate phenathrolines to be used as anticancerigenic agents
Enhanced structure for base with roller and belt of hardshell zipper case